Clinical Trials

Find trials by condition, location & phase

Drug Monographs

Browse drug monographs and information

Explore organizations and their profiles

Latest updates on trials and healthcare

Approved products by global authorities

AI-Powered Research

Discover powerful insights with advanced AI analysis tools for clinical trials.

Premium Access

Get unlimited access to our comprehensive pharmaceutical database and analytics.

Queen's University at Kingston

🇨🇦Canada

Country: 🇨🇦Canada

Ownership: Private

Established: 1841-10-16

Employees: 1K

Market Cap: -

Website: http://www.queensu.ca

Clinical Trials

Using Healthcare Financing and Digital Technology to Improve Hypertension Prevention and Control in Tanzania

Not Applicable

Not yet recruiting

Conditions: Hypertension
Diabetes

Interventions: Other: Nurse-delivered care using WelTel check-ins and BCC SMS
Other: Community-based peer-support model

First Posted Date: 2024-04-23

Last Posted Date: 2025-02-14

Lead Sponsor: Queen's University

Target Recruit Count: 1320

Registration Number: NCT06379750

STRatIfication of Vulvar SCC by HPV and p53 Status to Guide Excision

Not Applicable

Recruiting

Conditions: Vulvar Squamous Cell Carcinoma

Interventions: Other: Active Surveillance
Procedure: Surgery

First Posted Date: 2024-04-10

Last Posted Date: 2025-06-11

Lead Sponsor: Canadian Cancer Trials Group

Target Recruit Count: 249

Registration Number: NCT06358469

Locations: 🇨🇦
Hotel-Dieu de Quebec, Quebec City, Quebec, Canada
🇨🇦
BCCA - Vancouver, Vancouver, British Columbia, Canada
🇨🇦
Odette Cancer Centre, Toronto, Ontario, Canada

Determining the Impact of a Physiotherapist-led Primary Care Model for Hip and Knee Pain - A Cluster Trial

Not Applicable

Active, not recruiting

Conditions: Knee Osteoarthritis
Hip Osteoarthritis

Interventions: Other: Physiotherapist-led primary care model for hip and knee pain
Other: Usual physician-led primary care model for hip and knee pain

First Posted Date: 2024-04-10

Last Posted Date: 2024-12-05

Lead Sponsor: Queen's University

Target Recruit Count: 728

Registration Number: NCT06358521

Locations: 🇨🇦
Queen's University, Kingston, Ontario, Canada

Evaluating Changes in Skeletal Muscle Proteins Following Resistance Exercise and Single-Leg Disuse

Not Applicable

Recruiting

Conditions: Skeletal Muscle Hypertrophy
Healthy
Skeletal Muscle Atrophy

Interventions: Other: Immobilization
Other: Resistance training

First Posted Date: 2024-04-05

Last Posted Date: 2024-10-17

Lead Sponsor: Queen's University

Target Recruit Count: 14

Registration Number: NCT06350591

Locations: 🇨🇦
School of Kinesiology and Health Studies, Kingston, Ontario, Canada

Androgen Suppression Combined With Nodal Irradiation and Dose Escalated Prostate Treatment

Phase 3

Recruiting

Conditions: Prostate Cancer

Interventions: Radiation: Radiation
Radiation: Radiation SBRT only
Drug: ADT

First Posted Date: 2024-02-01

Last Posted Date: 2025-06-11

Lead Sponsor: Canadian Cancer Trials Group

Target Recruit Count: 710

Registration Number: NCT06235697

Locations: 🇺🇸
Siteman Cancer Center at West County Hospital, Creve Coeur, Missouri, United States
🇺🇸
Washington University School of Medicine, Saint Louis, Missouri, United States
🇺🇸
Siteman Cancer Center-South County, Saint Louis, Missouri, United States

and more 10 locations

Adjunctive Treatment With L-methylfolate for Treatment-Resistant Generalized Anxiety Disorder: a Pilot Study

Phase 4

Recruiting

Conditions: Generalized Anxiety Disorder

Interventions: Drug: L-methylfolate

First Posted Date: 2024-01-23

Last Posted Date: 2025-05-25

Lead Sponsor: Queen's University

Target Recruit Count: 10

Registration Number: NCT06218030

Locations: 🇨🇦
Kingston Health Sciences Centre, Kingston, Ontario, Canada

Neoadjuvant Chemotherapy, Excision And Observation vs Chemoradiotherapy For Rectal Cancer

Phase 3

Recruiting

Conditions: Rectal Cancer

Interventions: Drug: Fluoruracil
Drug: Leucovorin
Drug: Capecitabine
Drug: Oxaliplatin
Radiation: Radiation

First Posted Date: 2024-01-16

Last Posted Date: 2025-06-10

Lead Sponsor: Canadian Cancer Trials Group

Target Recruit Count: 250

Registration Number: NCT06205485

Locations: 🇺🇸
Cancer Center at Saint Joseph's, Phoenix, Arizona, United States
🇺🇸
UCI Health - Chao Family Comprehensive Cancer Center and Ambulatory Care, Irvine, California, United States
🇺🇸
UC Irvine Health/Chao Family Comprehensive Cancer Center, Orange, California, United States

and more 65 locations

Fixed Duration vs Continuous Daratumumab in Transplant Ineligible Older Adults With Newly Diagnosed Multiple Myeloma

Phase 3

Recruiting

Conditions: Multiple Myeloma

Interventions: Drug: Lenalidomide
Drug: Daratumumab
Drug: Dexamethasone

First Posted Date: 2023-12-27

Last Posted Date: 2025-06-11

Lead Sponsor: Canadian Cancer Trials Group

Target Recruit Count: 559

Registration Number: NCT06182774

Locations: 🇨🇦
Waterloo Regional Health Network (WRHN), Kitchener, Ontario, Canada
🇨🇦
Windsor Regional Cancer Centre, Windsor, Ontario, Canada
🇨🇦
BCCA - Kelowna, Kelowna, British Columbia, Canada

and more 22 locations

Paclitaxel and Ramucirumab +/- Zanidatamab in HER2 Postive Advanced Gastroesophageal Adenocarcinoma

Phase 2

Recruiting

Conditions: Gastroesophageal Adenocarcinoma

Interventions: Drug: Paclitaxel
Drug: Ramucirumab
Drug: Zanidatamab

First Posted Date: 2023-09-21

Last Posted Date: 2025-06-11

Lead Sponsor: Canadian Cancer Trials Group

Target Recruit Count: 168

Registration Number: NCT06043427

Locations: 🇨🇦
Waterloo Regional Health Network (WRHN), Kitchener, Ontario, Canada
🇨🇦
Centre Integre Universitaire De Sante Et De Services, Montreal, Quebec, Canada
🇨🇦
Arthur J.E. Child Comprehensive Cancer Centre, Calgary, Alberta, Canada

and more 15 locations

Ibrutinib Combination Therapy in Transplant Ineligible Individuals With Newly Diagnosed Primary CNS Lymphoma

Phase 2

Recruiting

Conditions: Non-hodgkin Lymphoma

Interventions: Drug: Methotrexate
Drug: Rituximab (where available)
Drug: Ibrutinib

First Posted Date: 2023-08-21

Last Posted Date: 2025-06-11

Lead Sponsor: Canadian Cancer Trials Group

Target Recruit Count: 30

Registration Number: NCT05998642

Locations: 🇨🇦
Arthur J.E. Child Comprehensive Cancer Centre, Calgary, Alberta, Canada
🇨🇦
BCCA - Vancouver, Vancouver, British Columbia, Canada
🇨🇦
Ottawa Hospital Research Institute, Ottawa, Ontario, Canada

and more 3 locations

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy